Wayfinder Biosciences
PrivateLast Round
Seed
Oct 17, 2022
Total Funding Raised
$4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Wayfinder Biosciences is a biotechnology company developing a new class of orally available RNA-targeting medicines to stop disease proteins before they are made.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wayfinder Biosciences Comparables
Compare Wayfinder Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 91% | |
| ReviR Therapeutics | 89% | |
| Ribometrix | 86% |
Wayfinder Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 17, 2022 | ||||
| Accelerator | Jan 14, 2022 |
Key People
Founding team and executive leadership
Wayfinder Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Notation Capital | Seed |
| Notley | Seed |
| IndieBio | Seed, Accelerator |
| BoxOne Ventures | Seed |
| Conscience VC | Seed |
| Joyance Partners | Seed |
| Overlap Holdings | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 52% MoM.
- Jun 21, 2026
Monthly visitors grew 72% MoM, reaching 1.4K.
Wayfinder Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Wayfinder Biosciences's valuation, stock price, and market status.
Is Wayfinder Biosciences a public or private company?
Wayfinder Biosciences is a private company.
What is the current stock price of Wayfinder Biosciences?
Wayfinder Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Wayfinder Biosciences worth (valuation)?
Valuation information for Wayfinder Biosciences is not publicly available.
Can I buy Wayfinder Biosciences stock?
Wayfinder Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Wayfinder Biosciences's last funding round?
Wayfinder Biosciences's most recent funding round was Seed on October 17, 2022.
Who are the main investors in Wayfinder Biosciences?
Key investors in Wayfinder Biosciences include Notation Capital, IndieBio, Divergent Capital.
Will Wayfinder Biosciences IPO soon?
No public IPO plans have been announced for Wayfinder Biosciences.
How can I track Wayfinder Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wayfinder Biosciences's secondary market activity and sign up for updates.